FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:SQRDL-MYH11

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: SQRDL-MYH11
FusionPDB ID: 86194
FusionGDB2.0 ID: 86194
HgeneTgene
Gene symbol

SQRDL

MYH11

Gene ID

58472

4629

Gene namesulfide quinone oxidoreductasemyosin heavy chain 11
SynonymsCGI-44|PRO1975|SQR|SQRDLAAT4|FAA4|SMHC|SMMHC
Cytomap

15q21.1

16p13.11

Type of geneprotein-codingprotein-coding
Descriptionsulfide:quinone oxidoreductase, mitochondrialsulfide dehydrogenase likesulfide quinone reductase-likemyosin-11epididymis secretory sperm binding proteinmyosin heavy chain, smooth muscle isoformmyosin, heavy chain 11, smooth musclemyosin, heavy polypeptide 11, smooth muscle
Modification date2020031320200322
UniProtAcc.

P35749

Main function of 5'-partner protein: FUNCTION: Muscle contraction.
Ensembl transtripts involved in fusion geneENST idsENST00000260324, ENST00000568606, 
ENST00000573908, ENST00000300036, 
ENST00000396324, ENST00000452625, 
ENST00000576790, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score5 X 4 X 5=10044 X 55 X 10=24200
# samples 562
** MAII scorelog2(5/100*10)=-1
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(62/24200*10)=-5.28659502177508
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: SQRDL [Title/Abstract] AND MYH11 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: SQRDL [Title/Abstract] AND MYH11 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)SQRDL(45954323)-MYH11(15815491), # samples:1
Anticipated loss of major functional domain due to fusion event.SQRDL-MYH11 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SQRDL-MYH11 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SQRDL-MYH11 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SQRDL-MYH11 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneSQRDL

GO:0070221

sulfide oxidation, using sulfide:quinone oxidoreductase

22852582

HgeneSQRDL

GO:0070813

hydrogen sulfide metabolic process

22852582



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr15:45954323/chr16:15815491)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across SQRDL (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across MYH11 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000568606SQRDLchr1545954323+ENST00000396324MYH11chr1615815491-29675941832147654
ENST00000568606SQRDLchr1545954323+ENST00000452625MYH11chr1615815491-30065941832045620
ENST00000568606SQRDLchr1545954323+ENST00000576790MYH11chr1615815491-23915941832045620
ENST00000568606SQRDLchr1545954323+ENST00000300036MYH11chr1615815491-21485941832147654
ENST00000260324SQRDLchr1545954323+ENST00000396324MYH11chr1615815491-31647913802344654
ENST00000260324SQRDLchr1545954323+ENST00000452625MYH11chr1615815491-32037913802242620
ENST00000260324SQRDLchr1545954323+ENST00000576790MYH11chr1615815491-25887913802242620
ENST00000260324SQRDLchr1545954323+ENST00000300036MYH11chr1615815491-23457913802344655

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000568606ENST00000396324SQRDLchr1545954323+MYH11chr1615815491-0.0120989490.9879011
ENST00000568606ENST00000452625SQRDLchr1545954323+MYH11chr1615815491-0.0109253770.98907465
ENST00000568606ENST00000576790SQRDLchr1545954323+MYH11chr1615815491-0.0068994070.99310064
ENST00000568606ENST00000300036SQRDLchr1545954323+MYH11chr1615815491-0.0051983390.99480164
ENST00000260324ENST00000396324SQRDLchr1545954323+MYH11chr1615815491-0.0135737650.98642623
ENST00000260324ENST00000452625SQRDLchr1545954323+MYH11chr1615815491-0.0121102970.9878897
ENST00000260324ENST00000576790SQRDLchr1545954323+MYH11chr1615815491-0.0106014880.9893985
ENST00000260324ENST00000300036SQRDLchr1545954323+MYH11chr1615815491-0.0096049610.990395

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for SQRDL-MYH11

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
SQRDLchr1545954323MYH11chr1615815491594137PDKNCIHTDDDEKLLAEEKNISSKYA
SQRDLchr1545954323MYH11chr1615815491791137PDKNCIHTDDDEKLLAEEKNISSKYA

Top

Potential FusionNeoAntigen Information of SQRDL-MYH11 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SQRDL-MYH11_45954323_15815491.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SQRDL-MYH11chr1545954323chr1615815491791HLA-B39:01IHTDDDEKL0.98890.7566514
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:01IHTDDDEKL0.98190.8608514
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:02IHTDDDEKL0.98110.862514
SQRDL-MYH11chr1545954323chr1615815491791HLA-B15:37IHTDDDEKL0.35530.5372514
SQRDL-MYH11chr1545954323chr1615815491791HLA-B13:02KLLAEEKNI0.04270.66231221
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:02IHTDDDEKLL0.98110.8782515
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:01IHTDDDEKLL0.98070.8726515
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:01NCIHTDDDEKL0.9050.7191314
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:02NCIHTDDDEKL0.89630.7202314
SQRDL-MYH11chr1545954323chr1615815491791HLA-C05:09HTDDDEKL10.9066614
SQRDL-MYH11chr1545954323chr1615815491791HLA-C08:15HTDDDEKL10.954614
SQRDL-MYH11chr1545954323chr1615815491791HLA-C04:07HTDDDEKLL0.99990.6585615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C05:09HTDDDEKLL0.99990.9123615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C04:10HTDDDEKLL0.99990.6642615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C08:15HTDDDEKLL0.99980.9586615
SQRDL-MYH11chr1545954323chr1615815491791HLA-B39:05IHTDDDEKL0.98310.7387514
SQRDL-MYH11chr1545954323chr1615815491791HLA-C04:06HTDDDEKLL0.92080.7141615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C08:13HTDDDEKLL0.81590.9297615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C08:04HTDDDEKLL0.81590.9297615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C08:03HTDDDEKLL0.5120.9683615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C05:09IHTDDDEKLL0.99840.9365515
SQRDL-MYH11chr1545954323chr1615815491791HLA-B39:05IHTDDDEKLL0.98290.7481515
SQRDL-MYH11chr1545954323chr1615815491791HLA-B39:05NCIHTDDDEKL0.89820.5537314
SQRDL-MYH11chr1545954323chr1615815491791HLA-C04:03HTDDDEKL10.7199614
SQRDL-MYH11chr1545954323chr1615815491791HLA-C08:02HTDDDEKL10.954614
SQRDL-MYH11chr1545954323chr1615815491791HLA-C05:01HTDDDEKL10.9066614
SQRDL-MYH11chr1545954323chr1615815491791HLA-C04:03HTDDDEKLL0.99990.7061615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C04:01HTDDDEKLL0.99990.6585615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C05:01HTDDDEKLL0.99990.9123615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C18:01HTDDDEKLL0.99990.7116615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C08:02HTDDDEKLL0.99980.9586615
SQRDL-MYH11chr1545954323chr1615815491791HLA-B39:31IHTDDDEKL0.98690.7558514
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:05IHTDDDEKL0.98190.8608514
SQRDL-MYH11chr1545954323chr1615815491791HLA-C15:05HTDDDEKLL0.93340.8465615
SQRDL-MYH11chr1545954323chr1615815491791HLA-B18:06DEKLLAEEK0.90780.79051019
SQRDL-MYH11chr1545954323chr1615815491791HLA-B15:09IHTDDDEKL0.8490.5361514
SQRDL-MYH11chr1545954323chr1615815491791HLA-C03:06HTDDDEKLL0.81850.9864615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C08:01HTDDDEKLL0.5120.9683615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C17:01HTDDDEKLL0.2230.7903615
SQRDL-MYH11chr1545954323chr1615815491791HLA-C05:01IHTDDDEKLL0.99840.9365515
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:05IHTDDDEKLL0.98070.8726515
SQRDL-MYH11chr1545954323chr1615815491791HLA-B38:05NCIHTDDDEKL0.9050.7191314

Top

Potential FusionNeoAntigen Information of SQRDL-MYH11 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SQRDL-MYH11_45954323_15815491.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0303DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0303DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0413EKLLAEEKNISSKYA1126
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0413DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0444EKLLAEEKNISSKYA1126
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0466DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0466DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0804DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0820DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0820DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0831DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-0831DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1104DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1104DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1106DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1118DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1134DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1134DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1135DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1135DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1138DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1138DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1141DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1142DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1142DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1143DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1143DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1144DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1144DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1146DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1146DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1147DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1150DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1150DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1153DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1153DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1156DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1156DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1157DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1157DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1158DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1158DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1160DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1160DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1173DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1173DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1177DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1177DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1178DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1178DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1179DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1179DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1182DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1183DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1183DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1184DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1184DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1188DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1188DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1193DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1306DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1309DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1311DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1311DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1337DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1337DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1342DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1342DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1344DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1344DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1360DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1381DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1381DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1385DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1385DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1389DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1389DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1394DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1394DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1402DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1402DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1406DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1406DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1409DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1409DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1412DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1415DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1417DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1417DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1419DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1419DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1420DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1420DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1421DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1421DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1424DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1429DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1429DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1430DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1430DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1434DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1434DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1437DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1437DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1441DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1441DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1447DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1452DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1452DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1480DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1480DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1481DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1483DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1483DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1484DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1484DDEKLLAEEKNISSK924
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1489DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1494DEKLLAEEKNISSKY1025
SQRDL-MYH11chr1545954323chr1615815491791DRB1-1494DDEKLLAEEKNISSK924

Top

Fusion breakpoint peptide structures of SQRDL-MYH11

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3515HTDDDEKLLAEEKNSQRDLMYH11chr1545954323chr1615815491791

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of SQRDL-MYH11

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3515HTDDDEKLLAEEKN-7.15543-7.26883
HLA-B14:023BVN3515HTDDDEKLLAEEKN-4.77435-5.80965
HLA-B52:013W393515HTDDDEKLLAEEKN-6.80875-6.92215
HLA-B52:013W393515HTDDDEKLLAEEKN-4.20386-5.23916
HLA-A11:014UQ23515HTDDDEKLLAEEKN-7.5194-8.5547
HLA-A11:014UQ23515HTDDDEKLLAEEKN-6.9601-7.0735
HLA-A24:025HGA3515HTDDDEKLLAEEKN-7.52403-7.63743
HLA-A24:025HGA3515HTDDDEKLLAEEKN-5.82433-6.85963
HLA-B27:056PYJ3515HTDDDEKLLAEEKN-3.28285-4.31815
HLA-B44:053DX83515HTDDDEKLLAEEKN-5.91172-6.94702
HLA-B44:053DX83515HTDDDEKLLAEEKN-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of SQRDL-MYH11

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
SQRDL-MYH11chr1545954323chr16158154911019DEKLLAEEKGACGAGAAGTTGTTAGCCGAGGAGAAA
SQRDL-MYH11chr1545954323chr16158154911221KLLAEEKNIAAGTTGTTAGCCGAGGAGAAAAACATC
SQRDL-MYH11chr1545954323chr1615815491314NCIHTDDDEKLAACTGCATTCACACAGATGACGACGAGAAGTTG
SQRDL-MYH11chr1545954323chr1615815491514IHTDDDEKLATTCACACAGATGACGACGAGAAGTTG
SQRDL-MYH11chr1545954323chr1615815491515IHTDDDEKLLATTCACACAGATGACGACGAGAAGTTGTTA
SQRDL-MYH11chr1545954323chr1615815491614HTDDDEKLCACACAGATGACGACGAGAAGTTG
SQRDL-MYH11chr1545954323chr1615815491615HTDDDEKLLCACACAGATGACGACGAGAAGTTGTTA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
SQRDL-MYH11chr1545954323chr16158154911025DEKLLAEEKNISSKYGACGAGAAGTTGTTAGCCGAGGAGAAAAACATCTCTTCCAAATAC
SQRDL-MYH11chr1545954323chr16158154911126EKLLAEEKNISSKYAGAGAAGTTGTTAGCCGAGGAGAAAAACATCTCTTCCAAATACGCG
SQRDL-MYH11chr1545954323chr1615815491924DDEKLLAEEKNISSKGACGACGAGAAGTTGTTAGCCGAGGAGAAAAACATCTCTTCCAAA

Top

Information of the samples that have these potential fusion neoantigens of SQRDL-MYH11

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
GBMSQRDL-MYH11chr1545954323ENST00000260324chr1615815491ENST00000300036TCGA-14-1034-02B

Top

Potential target of CAR-T therapy development for SQRDL-MYH11

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to SQRDL-MYH11

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to SQRDL-MYH11

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneMYH11C4707243Familial thoracic aortic aneurysm and aortic dissection10CLINGEN;GENOMICS_ENGLAND
TgeneMYH11C0023467Leukemia, Myelocytic, Acute2CTD_human
TgeneMYH11C0023479Acute myelomonocytic leukemia2CTD_human;ORPHANET
TgeneMYH11C0026998Acute Myeloid Leukemia, M12CTD_human
TgeneMYH11C1851504Aortic aneurysm, familial thoracic 42CTD_human;GENOMICS_ENGLAND;UNIPROT
TgeneMYH11C1879321Acute Myeloid Leukemia (AML-M2)2CTD_human
TgeneMYH11C1608393Megacystis microcolon intestinal hypoperistalsis syndrome1GENOMICS_ENGLAND;ORPHANET